国际肿瘤学杂志››2019,Vol. 46››Issue (7): 420-422.doi:10.3760/cma.j.issn.1673-422X.2019.07.006
周奇芬1吴春林2
出版日期:
2019-07-08发布日期:
2019-07-16通讯作者:
吴春林 E-mail:wuchunlin120@sina.comZhou Qifen1, Wu Chunlin2
Online:
2019-07-08Published:
2019-07-16Contact:
Wu Chunlin E-mail:wuchunlin120@sina.com摘要:泛素特异性蛋白酶是去泛素化酶家族中的一员,能逆转蛋白质的泛素化降解,从而达到稳定蛋白质的目的。其通过调控肿瘤细胞的DNA损伤、细胞周期、核转录因子κB信号通路、Nrf2Keap1信号通路、癌基因cmyc等,影响肿瘤对放疗的敏感性,有望成为肿瘤放疗增敏的新靶点。
周奇芬,吴春林. 泛素特异性蛋白酶对肿瘤放疗敏感性的影响[J]. 国际肿瘤学杂志, 2019, 46(7): 420-422.
Zhou Qifen, Wu Chunlin. Effect of ubiquitin-specific protease on radiosensitivity of tumor[J]. Journal of International Oncology, 2019, 46(7): 420-422.
[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394424. DOI: 10.3322/caac.21492. [2] Bristow RG, Alexander B, Baumann M, et al. Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology[J]. Lancet Oncol, 2018, 19(5): e240e251. DOI: 10.1016/S14702045(18)300962. [3] de Poot SAH, Tian G, Finley D. Meddling with fate: the proteasomal deubiquitinating enzymes[J]. J Mol Biol, 2017, 429(22): 35253545. DOI: 10.1016/j.jmb.2017.09.015. [4] Wieringa HW, van der Zee AG, de Vries EG, et al. Breaking the DNA damage response to improve cervical cancer treatment[J]. Cancer Treat Rev, 2016, 42: 3040. DOI: 10.1016/j.ctrv.2015.11.008. [5] Wang Z, Zhang H, Liu J, et al. USP51 deubiquitylates H2AK13, 15ub and regulates DNA damage response[J]. Genes Dev, 2016, 30(8): 946959. DOI: 10.1101/gad.271841.115. [6] Zhang L, Nemzow L, Chen H, et al. The deubiquitinating enzyme USP24 is a regulator of the UV damage response[J]. Cell Rep, 2015, 10(2): 140147. DOI: 10.1016/j.celrep.2014.12.024. [7] Zhang W, Sartori MA, Makhnevych T, et al. Generation and validation of intracellular ubiquitin variant inhibitors for USP7 and USP10[J]. J Mol Biol, 2017, 429(22): 35463560. DOI: 10.1016/j.jmb.2017.05.025. [8] Liu J, Kruswick A, Dang H, et al. Ubiquitinspecific protease 21 stabilizes BRCA2 to control DNA repair and tumor growth[J]. Nat Commun, 2017, 8(1): 137149. DOI: 10.1038/s41467017002062. [9] PerezOliva AB, Lachaud C, Szyniarowski P, et al. USP45 deubiquitylase controls ERCC1XPF endonucleasemediated DNA damage responses[J]. EMBO J, 2015, 34(3): 326343. DOI: 10.15252/embj.201489184. [10] Li Y, Huang W, Xu Y, et al. CYLD deubiquitinase negatively regulates high glucoseinduced NFkappaB inflammatory signaling in mesangial cells[J]. Biomed Res Int, 2017, 2017: 3982906. DOI: 10.1155/2017/3982906. [11] Liu C, Wang L, Chen W, et al. USP35 activated by miR let7a inhibits cell proliferation and NFκB activation through stabilization of ABIN2[J]. Oncotarget, 2015, 6(29): 2789127906. DOI: 10.18632/oncotarget.4451. [12] Poalas K, Hatchi EM, Cordeiro N, et al. Negative regulation of NFκB signaling in T lymphocytes by the ubiquitinspecific protease USP34[J]. Cell Commun Signal, 2013, 11(1): 25. DOI: 10.1186/1478811X1125. [13] Li G, Wang Z, Chong T, et al. Curcumin enhances the radiosensitivity of renal cancer cells by suppressing NFκB signaling pathway[J]. Biomed Pharmacother, 2017, 94: 974981. DOI: 10.1016/j.biopha.2017.07.148. [14] Ren K, Li Z, Li Y, et al. Sulforaphene enhances radiosensitivity of hepatocellular carcinoma through suppression of the NFκB pathway[J]. J Biochem Mol Toxicol, 2017, 31(8): e21917. DOI: 10.1002/jbt.21917. [15] Villeneuve NF, Tian W, Wu T, et al. USP15 negatively regulates Nrf2 through deubiquitination of Keap1[J]. Mol Cell, 2013, 51(1): 6879. DOI: 10.1016/j.molcel.2013.04.022. [16] Boustani MR, Khoshnood RJ, Nikpasand F, et al. Overexpression of ubiquitinspecific protease 2a (USP2a) and nuclear factor erythroid 2related factor 2 (Nrf2) in human gliomas[J]. J Neurol Sci, 2016, 363: 249252. DOI: 10.1016/j.jns.2016.03.003. [17] Hou K, Zhu Z, Wang Y, et al. Overexpression and biological function of ubiquitinspecific protease 42 in gastric cancer[J]. PLoS One, 2016, 11(3): e0152997. DOI: 10.1371/journal.pone.0152997. [18] Hu W, Wei H, Li K, et al. Downregulation of USP32 inhibits cell proliferation, migration and invasion in human small cell lung cancer[J]. Cell Prolif, 2017, 50(4): e12343. DOI: 10.1111/cpr.12343. [19] Kim J, D′annibale S, Magliozzi R, et al. USP17and SCFβTrCPregulated degradation of DEC1 controls the DNA damage response[J]. Mol Cell Biol, 2014, 34(22): 41774185. DOI: 10.1128/MCB.0053014. [20] McKeown MR, Bradner JE. Therapeutic strategies to inhibit MYC[J]. Cold Spring Harb Perspect Med, 2014, 4(10). pii: a014266. DOI: 10.1101/cshperspect.a014266. [21] Diefenbacher ME, Popov N, Blake SM, et al. The deubiquitinase USP28 controls intestinal homeostasis and promotes colorectal cancer[J]. J Clin Invest, 2014, 124(8): 34073418. DOI: 10.1172/JCI73733. [22] Pan J, Deng Q, Jiang C, et al. USP37 directly deubiquitinates and stabilizes cMyc in lung cancer[J]. Oncogene, 2015, 34(30): 39573967. DOI: 10.1038/onc.2014.327. [23] Sun XX, He X, Yin L, et al. The nucleolar ubiquitinspecific protease USP36 deubiquitinates and stabilizes cMyc[J]. Proc Natl Acad Sci U S A, 2015, 112(12): 37343739. DOI: 10.1073/pnas.1411713112. |
[1] | 刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲.血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325. |
[2] | 杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊.局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337. |
[3] | 袁健, 黄燕华.Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343. |
[4] | 陈红健, 张素青.血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349. |
[5] | 郭泽浩, 张俊旺.PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353. |
[6] | 张百红, 岳红云.新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358. |
[7] | 许凤琳, 吴刚.EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363. |
[8] | 王盈, 刘楠, 郭兵.抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369. |
[9] | 张蕊, 褚衍六.基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375. |
[10] | 高凡, 王萍, 杜超, 褚衍六.肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381. |
[11] | 王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东.ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384. |
[12] | 刘静, 刘芹, 黄梅.基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273. |
[13] | 杨琳, 路宁, 温华, 张明鑫, 朱琳.炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279. |
[14] | 王俊毅, 洪楷彬, 纪荣佳, 陈大朝.癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285. |
[15] | 张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志.宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||